At a glance
ClinicalIndex Comparison RecordN/ACompleted· 471 enrolled
Drug / intervention
no intervention +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
NON INTERVENTIONAL STUDY (NIS) IN PATIENTS WITH BIPOLAR DISCORDER (MANIC OR MIXED EPISODES) AND SCHIZOPHRENIA UNDERGOING TREATEMENT WITH ZELDOX
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.·observational·Posted Oct 2, 2007·Updated Nov 18, 2022
In Brief
An observational study evaluating no intervention for Bipolar Disorder and Schizophrenia. Completed, enrolled 471 participants.
Detailed Summary
Investigation of the impact of Zeldox on metabolic parametres in patients with bipolar disorder or with schizophrenia and impact of the treatment for the quality of life
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsBipolar Disorder, Schizophrenia
Countries--
Collaborators--
Timeline
N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 2007
Enrollment StartOct 2007
Primary CompletionApr 2008
TodayJul 2026
First PostedOct 2, 2007
Enrollment StartOct 16, 2007
Primary CompletionApr 30, 2008
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 18.8 years ago
Interventions
no interventionother
no intervention
no interventionother
no intervention